Can a phone call replace the Doctor's office for cancer genetic testing?
NCT ID NCT07471958
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether people are interested in using telehealth and digital tools for genetic counseling and testing for hereditary cancer. 360 adults who meet guidelines for genetic testing will receive counseling at home and may use optional digital tools. The goal is to see how many complete the process and how they feel about it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telehealth genetic counseling and digital tools
What this could lead to
If successful, this could show that remote genetic testing is a practical option, making it easier for more people to access cancer risk information.
What could go wrong
This is an early-stage study focused on patient interest and feasibility, not on health outcomes. It may not prove that telehealth improves cancer detection or survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Abramson Cancer Center at the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••